Can urinary biomarkers replace cystoscopy?

Maas, Moritz; Bedke, Jens; Stenzl, Arnulf; Todenhöfer, Tilman

Maas, Moritz; Bedke, Jens; Stenzl, Arnulf; Todenhöfer, Tilman.

Affiliation

Maas M; Department of Urology, University Hospital Tuebingen, Hoppe-Seyler-Straße 3, 72076, Tuebingen, Germany.
Bedke J; Department of Urology, University Hospital Tuebingen, Hoppe-Seyler-Straße 3, 72076, Tuebingen, Germany.
Stenzl A; Department of Urology, University Hospital Tuebingen, Hoppe-Seyler-Straße 3, 72076, Tuebingen, Germany.
Todenhöfer T; Department of Urology, University Hospital Tuebingen, Hoppe-Seyler-Straße 3, 72076, Tuebingen, Germany. tilman.todenhoefer@med.uni-tuebingen.de.

World J Urol ; 37(9): 1741-1749, 2019 Sep.

Article in En | MEDLINE | ID: mdl-30283995

Subject(s)

Biomarkers, Tumor/urine; Cystoscopy; Urinary Bladder Neoplasms/diagnosis; Urinary Bladder Neoplasms/urine; Decision Trees; Humans; Neoplasm Invasiveness; Urinary Bladder Neoplasms/pathology; Urine/cytology

Key words

Disease detection; Follow-up; Liquid biopsy; Molecular urine markers; Non-muscle invasive bladder cancer; cfDNA

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Biomarkers, Tumor / Cystoscopy Type of study: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: World J Urol Year: 2019 Document type: Article Affiliation country: Germany Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google